Enhancement of feline immunodeficiency virus (FIV) infection after DNA vaccination with the FIV envelope.
about
Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infectionKinetics of replication of a partially attenuated virus and of the challenge virus during a three-year intersubtype feline immunodeficiency virus superinfection experiment in cats.DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies.AIDS vaccination studies with an ex vivo feline immunodeficiency virus model: analysis of the accessory ORF-A protein and DNA as protective immunogensFeline immunodeficiency virus (FIV) neutralization: a reviewConserved epitopes on HIV-1, FIV and SIV p24 proteins are recognized by HIV-1 infected subjects.Antibodies generated in cats by a lipopeptide reproducing the membrane-proximal external region of the feline immunodeficiency virus transmembrane enhance virus infectivity.Enhanced SIV replication and accelerated progression to AIDS in macaques primed to mount a CD4 T cell response to the SIV envelope proteinPassive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose.Delayed infection after immunization with a peptide from the transmembrane glycoprotein of the feline immunodeficiency virus.Immunogenicity of an anti-clade B feline immunodeficiency fixed-cell virus vaccine in field cats.Feline leukemia virus DNA vaccine efficacy is enhanced by coadministration with interleukin-12 (IL-12) and IL-18 expression vectors.Association of plasma viral RNA load with prognosis in cats naturally infected with feline immunodeficiency virusThe Comparative Value of Feline Virology Research: Can Findings from the Feline Lentiviral Vaccine Be Translated to Humans?Conserved HIV Epitopes for an Effective HIV Vaccine.Applications of the FIV Model to Study HIV Pathogenesis.FIV vaccine with receptor epitopes results in neutralizing antibodies but does not confer resistance to challenge.
P2860
Q21245045-608D2E75-BA24-4386-920C-3415A20F2B4FQ33641801-B58B34A0-CC08-45C1-A1CF-59191DBA88B0Q33783841-A6A1A5FF-CF9B-4603-9DF9-C0386B535B4EQ35024266-DF697C83-F12F-44EF-80E6-2CD46DDA31F3Q35491705-09D51568-46D8-43ED-88AF-5A51EF164D9FQ35887491-5E5E9ED4-7D66-48D1-AB30-0133DF3779F3Q36097111-BA8B202F-CE93-4FE7-9D47-A0D5C82C6D1FQ37511699-709A1F4B-AF5D-478A-B91E-49E6394BC0C1Q37528015-A56FEFCF-6EF1-4464-8137-D996B413F66CQ39577967-1EB9E356-9FB3-4AB5-85C3-EE5397B9D163Q39597617-63BA6116-5E5E-4942-9B08-3A023039D59BQ39606955-DC2CF036-A414-4B0D-BB5F-46907EC2D00FQ39684704-D57EDA3B-102D-42B3-BFD2-BF95F3B90D02Q43378526-1A74F3EE-169B-4465-90D1-0C755D810DB5Q47093684-097BF1C7-F365-42DB-AD6D-D2C5D0B25DB0Q52574472-A2980570-3D6A-4199-9926-39404A3D6A1BQ53686365-F1632640-DF44-4D7A-8873-A4373A075723
P2860
Enhancement of feline immunodeficiency virus (FIV) infection after DNA vaccination with the FIV envelope.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Enhancement of feline immunode ...... ination with the FIV envelope.
@ast
Enhancement of feline immunode ...... ination with the FIV envelope.
@en
type
label
Enhancement of feline immunode ...... ination with the FIV envelope.
@ast
Enhancement of feline immunode ...... ination with the FIV envelope.
@en
prefLabel
Enhancement of feline immunode ...... ination with the FIV envelope.
@ast
Enhancement of feline immunode ...... ination with the FIV envelope.
@en
P2093
P2860
P1433
P1476
Enhancement of feline immunode ...... ination with the FIV envelope.
@en
P2093
P2860
P304
P407
P577
1997-12-01T00:00:00Z